COMPARISON OF DRUG-ELUTING STENTS VERSUS BARE METAL STENTS FOR THE TREATMENT OF CORONARY ARTERY DISEASE

B  KHAN; AT KHAN; A MUHAMMAD; S SAWAR; F RAHMAN; M  HASSAN

doi:10.54112/bcsrj.v2023i1.273

Authors

B KHAN Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
AT KHAN Department of Medicine, Hayatabad Medical Complex, Peshawar, Pakistan
A MUHAMMAD Department of Medicine, Khalifa Gulnawaz Hospital, Bannu, Pakistan
S SAWAR Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
F RAHMAN Department of Radiology, Hayatabad Medical Complex, Peshawar, Pakistan
M HASSAN Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.273

Keywords:

Cardiovascular Risk Factors, Percutaneous Coronary Intervention,, Bare-Metal Stents, Coronary Artery Disease, Drug-Eluting Stents

Abstract

Coronary artery disease is a condition that affects millions of people worldwide and can lead to serious complications such as heart attack or stroke. The study's main objective is to compare drug-eluting stents versus bare-metal stents for treating coronary artery disease. The present study aimed to compare the efficacy and safety of drug-eluting stents (DES) versus bare metal stents (BMS) for the treatment of coronary artery disease (CAD). The study was conducted at two tertiary care hospitals, Hayatabad Medical Complex and Lady Reading Hospital in Peshawar, Pakistan, from July 2019 to July 2020. The study included a total of 384 patients with CAD who underwent percutaneous coronary intervention (PCI) with either DES or BMS. The study included a total of 384 patients with CAD who underwent PCI with either DES or BMS. The mean age of the study participants was 58.2 ± 9.4 years, and 75.8% were male. The baseline characteristics, including demographic data, clinical presentation, cardiovascular risk factors, and angiographic findings, were comparable between the two groups. In conclusion, our study contrasting medication-eluting stents versus exposed metal stents for treating coronary supply route sickness found that drug-eluting stents were related to a lower chance of unfriendly heart occasions, including objective vessel revascularization, dead myocardial tissue, and cardiovascular demise, contrasted with uncovered metal stents.

Downloads

Download data is not yet available.

References

Bangalore S, Kumar S, Fusaro M, et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117,762 patient-years of follow-up from randomized trials. Circulation. 2012;125(23):2873-2891.

Eltchaninoff H, Gueret P, Lefevre T, et al. Six-month angiographic and clinical results of the multicenter randomized study comparing a paclitaxel drug-eluting stent with a bare metal stent in saphenous vein grafts. Circulation. 2006;113(8):1323-1329.

Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006;27:2784-2814

Jensen LO, Thayssen P, Christiansen EH, et al. Safety and efficacy of everolimus- versus sirolimus-eluting stents: 5-year results from SORT OUT IV. J Am Coll Cardiol 2016;67:751-762

Räber L, Magro M, Stefanini GG, et al. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation 2012;125:1110-1121

Singh IM, Filby SJ, El Sakr F, Gorodeski EZ, Lincoff AM, Ellis SG, Shishehbor MH. Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis. Catheter Cardiovasc Interv. 2010 Aug 1;76(2):257-62. doi: 10.1002/ccd.22509. PMID: 20665874; PMCID: PMC3786735.

Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR., Jr Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation. 2007;116(21):2391–8.

Schuhlen H, Kastrati A, Mehilli J, Hausleiter J, Pache J, Dirschinger J, Schomig A. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J. 2004;147(2):317–22.

Lai CH, Lee WL, Sung SH, Hsu PF, Chen YH, Chan WL, Lin SJ, Lu TM. Comparison of Bare-Metal Stent and Drug-Eluting Stent for the Treatment of Patients Undergoing Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease - Long-Term Result from a Single Center Experience. Acta Cardiol Sin. 2015 Sep;31(5):381-9. doi: 10.6515/acs20140630g. PMID: 27122897; PMCID: PMC4804801.

Liu, L., Liu, B., Ren, J. et al. Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 18, 46 (2018). https://doi.org/10.1186/s12872-018-0771-y

Jia B, Zhang X, Ma N, et al. Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial. JAMA Neurol. 2022;79(2):176–184. doi:10.1001/jamaneurol.2021.4804

Bundhun, Pravesh, et al. "Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials." PLOS ONE, vol. 11, no. 4, 2016, p. e0154064, https://doi.org/10.1371/journal.pone.0154064.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcareinterventions: explanation and elaboration. BMJ. 2009; 339:b2700. pmid:19622552

Di Lorenzo E, De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, et al. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) RandomizedTrial. JACC Cardiovasc Interv. 2009; 2(6):515–23.

Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, et al; HORIZONS-AMI Trial Investigators. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009; 3